# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-118282
Filing Date
2024-04-26
Accepted
2024-04-26 16:52:57
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | d804729dars.pdf | ARS | 1632433
| Complete submission text file | 0001193125-24-118282.txt |  | 2249594

Mailing Address 2617 BISSONNET ST SUITE 225 HOUSTON TX 77005
Business Address 2617 BISSONNET ST SUITE 225 HOUSTON TX 77005 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-33038 | Film No.: 24884799
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)